Botanix Pharmaceuticals Ltd - ESG Rating & Company Profile powered by AI
If you are employed by Botanix Pharmaceuticals Ltd and you wish to use your ESG rating, please contact us. This page is a zero-cost E,S&G report for Botanix Pharmaceuticals Ltd. The article contains a Q&A table about Botanix Pharmaceuticals Ltd.
Botanix Pharmaceuticals Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.2; made up of an environmental score of 5.3, social score of 3.2 and governance score of 4.0.
4.2
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
951 | Purple Biotech Ltd | 4.3 | High |
951 | Vectura Group Services Ltd | 4.3 | High |
969 | Botanix Pharmaceuticals Ltd | 4.2 | High |
969 | Arvinas Inc | 4.2 | High |
969 | Adamas Pharmaceuticals Inc | 4.2 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Botanix Pharmaceuticals Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Botanix Pharmaceuticals Ltd disclose current and historical energy intensity?
Does Botanix Pharmaceuticals Ltd report the average age of the workforce?
Does Botanix Pharmaceuticals Ltd reference operational or capital allocation in relation to climate change?
Does Botanix Pharmaceuticals Ltd disclose its ethnicity pay gap?
Does Botanix Pharmaceuticals Ltd disclose cybersecurity risks?
Does Botanix Pharmaceuticals Ltd offer flexible work?
Does Botanix Pharmaceuticals Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Botanix Pharmaceuticals Ltd disclose the number of employees in R&D functions?
Does Botanix Pharmaceuticals Ltd conduct supply chain audits?
Does Botanix Pharmaceuticals Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Botanix Pharmaceuticals Ltd conduct 360 degree staff reviews?
Does Botanix Pharmaceuticals Ltd disclose the individual responsible for D&I?
Does Botanix Pharmaceuticals Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Botanix Pharmaceuticals Ltd disclose current and / or historical scope 2 emissions?
Does Botanix Pharmaceuticals Ltd disclose water use targets?
Does Botanix Pharmaceuticals Ltd have careers partnerships with academic institutions?
Did Botanix Pharmaceuticals Ltd have a product recall in the last two years?
Does Botanix Pharmaceuticals Ltd disclose incidents of discrimination?
Does Botanix Pharmaceuticals Ltd allow for Work Councils/Collective Agreements to be formed?
Has Botanix Pharmaceuticals Ltd issued a profit warning in the past 24 months?
Does Botanix Pharmaceuticals Ltd disclose parental leave metrics?
Does Botanix Pharmaceuticals Ltd disclose climate scenario or pathway analysis?
Does Botanix Pharmaceuticals Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Botanix Pharmaceuticals Ltd disclose the pay ratio of women to men?
Does Botanix Pharmaceuticals Ltd support suppliers with sustainability related research and development?
Does Botanix Pharmaceuticals Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Botanix Pharmaceuticals Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Botanix Pharmaceuticals Ltd involved in embryonic stem cell research?
Does Botanix Pharmaceuticals Ltd disclose GHG and Air Emissions intensity?
Does Botanix Pharmaceuticals Ltd disclose its waste policy?
Does Botanix Pharmaceuticals Ltd report according to TCFD requirements?
Does Botanix Pharmaceuticals Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Botanix Pharmaceuticals Ltd disclose energy use targets?
Does Botanix Pharmaceuticals Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Botanix Pharmaceuticals Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Botanix Pharmaceuticals Ltd
These potential risks are based on the size, segment and geographies of the company.
Botanix Pharmaceuticals Limited engages in the research and development of dermatology and antimicrobial products in Australia. The company engages in development of novel treatments for common skin diseases and infections. Its product pipeline includes Sofpironium Bromide, a drug in development for the treatment of primary axillary hyperhidrosis that has completed Phase 3 clinical programs; BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers that has completed Phase II clinical trials; BTX 1801, which has completed Phase IIb clinical trials for the treatment of staphylococcus aureus and methicillin resistant staphylococcus aureus; BTX 1702 that is in Phase IIb clinical trials for the treatment of papulopustular rosacea; and BTX 1204A for the treatment of atopic dermatitis. The company was incorporated in 1984 and is based in Leederville, Australia.